← Leaderboards
Ted Ross
University Of Georgia
$74,568,888
Attributed
$74,568,888
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $13.9M · FY2019–25$20M$15M$10M$5M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$74,568,888 · 1
By mechanism
N01$74,568,888 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Georgia
Same institution · by research overlap
- Balazs Rada$5,784,336
- Ralph A Tripp$7,550,886
- Fikri Y Avci$6,406,567
- Michael Stephen Trent$20,572,599
- Jarrod Mousa$10,148,469
Others in their field
Other Emerging Leaders on “Immune Response”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Yunda Huang · Fred Hutchinson Cancer Center$72,098,149
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Scott Hensley · University Of Pennsylvania$49,058,212
- Michelle Lynn Sever · Rho Federal Systems Division, Inc.$31,478,763
Research focus
Immune ResponseHigh Risk PopulationUniversitiesInfectionPregnantRecording Of Previous EventsResponseInfluenza Virus VaccineNational Institute Of Allergy And Infectious DiseaseMucous MembraneImmuneNovel VaccinesHigh RiskProgramsContractsImmunityContractorAnti-InfluenzaAnimalsAnimal ModelElderlyInnovationImmunogenicityNext Generation
Grant awards (14)
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations$8,000,000
N01 · FY2025 · AI · contact PI
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations$2,949,775
N01 · FY2024 · AI · contact PI
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations$2,949,775
N01 · FY2024 · AI · contact PI
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations$2,949,775
N01 · FY2024 · AI · contact PI
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations$10,700,042
N01 · FY2023 · AI · contact PI
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations$10,188,376
N01 · FY2022 · AI · contact PI
COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,$2,229,415
N01 · FY2022 · AI · contact PI
COVID supplement: A multi-site study seeking to study immune responses developed after infection with SARS-CoV-2$61,062
N01 · FY2022 · AI · contact PI
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations$12,275,590
N01 · FY2021 · AI · contact PI
COVID supplement: A multi-site study seeking to study immune responses developed after infection with SARS-CoV-2$1,575,867
N01 · FY2021 · AI · contact PI
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations$10,749,810
N01 · FY2020 · AI · contact PI
COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,$969,746
N01 · FY2020 · AI · contact PI
COVID supplement: A multi-site study seeking to study immune responses developed after infection with SARS-CoV-2$969,655
N01 · FY2020 · AI · contact PI
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations$8,000,000
N01 · FY2019 · AI · contact PI